| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
13,870,000 |
| Market
Cap: |
583.93(M) |
| Last
Volume: |
2,897,500 |
Avg
Vol: |
64,821 |
| 52
Week Range: |
$17.67 - $38.49 |
|
| Level
I Sector: |
Basic Materials |
| Level
II Sector: |
Chemicals |
| Level
III Sector: |
Specialty Chemicals |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Surmodics is a provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Co.'s segments are: Medical Device, which develops and manufactures vascular intervention medical device products and is engaged in Co.'s proprietary surface modification coating technologies that impart lubricity, pro-healing, biocompatibility characteristics, or drug-delivery capabilities to medical devices and delivery systems; and IVD, which manufactures and sells components for IVD immunoassay and molecular tests within the diagnostic, biomedical research, and life science markets.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
9,872 |
| Total Sell Value |
$0 |
$0 |
$0 |
$335,339 |
| Total People Sold |
0 |
0 |
0 |
3 |
| Total Sell Transactions |
0 |
0 |
0 |
3 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Robey Brian L |
VP & Gen Mgr Drug Delivery |
• – – |
2008-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,552 |
6,218 |
|
- |
|
| Phillips Bryan K |
VP, Gen Counsel & Secretary |
• – – |
2008-11-17 |
4 |
D |
$24.25 |
$17,969 |
D/D |
(741) |
3,527 |
|
- |
|
| Phillips Bryan K |
VP, Gen Counsel & Secretary |
• – – |
2008-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,268 |
4,268 |
|
- |
|
| Lopez Paul A |
Vice President |
• – – |
2008-11-17 |
4 |
D |
$24.25 |
$12,125 |
D/D |
(500) |
41,160 |
|
- |
|
| Lopez Paul A |
Vice President |
• – – |
2008-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,400 |
41,660 |
|
- |
|
| Olson Charles W |
VP & Gen Mgr, Hydroph Tech |
• – – |
2008-11-17 |
4 |
D |
$24.25 |
$20,225 |
D/D |
(834) |
29,194 |
|
- |
|
| Olson Charles W |
VP & Gen Mgr, Hydroph Tech |
• – – |
2008-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,552 |
30,028 |
|
- |
|
| Duran Lise W |
VP & Gen Mgr, Regen Tech |
• – – |
2008-11-17 |
4 |
D |
$24.25 |
$13,483 |
D/D |
(556) |
60,477 |
|
- |
|
| Duran Lise W |
VP & Gen Mgr, Regen Tech |
• – – |
2008-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,701 |
61,033 |
|
- |
|
| Astry Douglas P |
Gen Mgr, In Vitro Technologies |
• – – |
2008-11-17 |
4 |
D |
$24.25 |
$8,973 |
D/D |
(370) |
7,141 |
|
- |
|
| Astry Douglas P |
Gen Mgr, In Vitro Technologies |
• – – |
2008-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,134 |
7,511 |
|
- |
|
| Barclay Bruce |
President & CEO |
• • – |
2008-11-17 |
4 |
D |
$24.25 |
$62,929 |
D/D |
(2,595) |
93,703 |
|
- |
|
| Barclay Bruce |
President & CEO |
• • – |
2008-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
7,938 |
96,298 |
|
- |
|
| Ankeny Philip D |
Senior VP & CFO |
• – – |
2008-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,552 |
35,695 |
|
- |
|
| Anderson Aron B |
VP & Chief Scientific Officer |
• – – |
2008-11-17 |
4 |
D |
$24.25 |
$13,483 |
D/D |
(556) |
37,792 |
|
- |
|
| Anderson Aron B |
VP & Chief Scientific Officer |
• – – |
2008-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,701 |
38,348 |
|
- |
|
| Tipton Arthur J |
Vice President |
• – – |
2008-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,383 |
17,816 |
|
- |
|
| Lehman Mark A. |
Treasurer |
• – – |
2008-07-31 |
4 |
B |
$41.85 |
$4,185 |
D/D |
100 |
1,100 |
2.66 |
- |
|
| Robey Brian L |
VP & Gen Mgr Drug Delivery |
• – – |
2008-06-02 |
4 |
D |
$45.14 |
$26,181 |
D/D |
(580) |
7,445 |
|
- |
|
| Lehman Mark A. |
Treasurer |
• – – |
2008-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
1,000 |
|
- |
|
| Anderson Aron B |
VP & Chief Scientific Officer |
• – – |
2008-05-09 |
4/A |
OE |
$34.85 |
$87,125 |
D/D |
2,500 |
36,647 |
|
- |
|
| Anderson Aron B |
VP & Chief Scientific Officer |
• – – |
2008-05-09 |
4 |
OE |
$34.85 |
$87,125 |
D/D |
2,500 |
38,485 |
|
- |
|
| Anderson Aron B |
VP & Chief Scientific Officer |
• – – |
2008-05-09 |
4 |
S |
$43.88 |
$80,653 |
D/D |
(1,838) |
34,147 |
|
- |
|
| Duran Lise W |
VP & Gen Mgr, Regen Tech |
• – – |
2008-04-30 |
4 |
S |
$44.75 |
$89,750 |
D/D |
(2,000) |
59,332 |
|
- |
|
| Olson Charles W |
VP & Gen Mgr, Hydroph Tech |
• – – |
2008-03-21 |
4 |
D |
$40.07 |
$36,985 |
D/D |
(923) |
27,476 |
|
- |
|
888 Records found
|
|
Page 29 of 36 |
|
|
